Reaching new levels in synthetic bone grafting
|
|
- Extended Reach
- Controlled Delivery
- Precise Placement
- Contains Actifuse ABX
Ideal for use in a range of spine and orthopaedic procedures:
|
|
 Bone Void Filling |
 |
 |
| Acetabular Cysts | Fracture Repair (with appropriate stabilizing hardware) |
Posterolateral Fusion
Designed for ease of use
| Key Design Features |
|
| Cartridge Working Length | 200mm |
| Cartridge Outside Diameter |
8mm |
| Cartridge Fill Volume |
7.5ml |
| Delivery Volume Full Squeeze Half Squeeze |
|
| Product Code |
Pack Size |
| 506005078070 | Applicator plus 1 x 7.5ml Cartridge |
| 506005078072 |
Refill Cartridge 1 x 7.5ml |
The Actifuse Family of Synthetic Bone Graft Products are FDA 510(k) cleared in the United States for orthopedic applications as a filler for gaps and voids that are not intrinsic to the stability of the bony structure. In addition, Actifuse is intended to fill, augment and/or reconstruct maxillofacial osseous bone defects, including periodontal, oral and craniomaxillofacial applications. The Products are indicated to be gently packed into bony voids or gaps of the skeletal system, i.e., extremities, pelvis, and spine, including use in posterolateral spinal fusion procedures with appropriate stabilizing hardware. These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. Actifuse is cleared for use on a standalone basis however it can be mixed with sterile saline/water, autologous blood or bone marrow aspirate at the discretion of the surgeon. A copy of the full Actifuse IFU for the US market, containing specific information on indications of use, contraindications, warnings, precautions, and adverse reaction information, is enclosed with the product or is available upon request from ApaTech. TOP
